## JPM: JPMorgan Chase & Co. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.4% in lower entry zone (4.0-10.0%), top quartile (83rd pct) cross-sectional ranking. Short-term MRS_5 (2.4%) confirms momentum alignment. Strong momentum (+2.5% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($322.12)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. This is how JPMorgan Chase’s stock stands out in the elite $900 billion club**
- Source: MarketWatch | 20260105T124500 | Bullish | Relevance: 100%
- JPMorgan Chase is on the verge of closing with a market capitalization exceeding $900 billion for the first time, making it the 13th U.S. company to reach this milestone. This achievement places the financial giant in an exclusive club where its stock stands out as the cheapest among its peers. The company's stock rallied 3% intraday, pushing it towards this significant valuation.

**2. JPMorgan stock holds near record highs as Wall Street braces for Jan. 13 earnings and key U.S. data**
- Source: ts2.tech | 20260104T171900 | Somewhat-Bullish | Relevance: 100%
- JPMorgan Chase & Co. shares closed up about 1% at $325.48, with investors anticipating quarterly results on January 13, 2026. The market is weighing early optimism against upcoming economic data and bank earnings, especially with the Federal Reserve's recent rate cuts. Key events include the December Employment Situation report on January 9 and the Consumer Price Index on January 13, the same day JPMorgan will release its earnings.

**3. JPMorgan stock closes higher to start 2026 — what investors watch before earnings**
- Source: ts2.tech | 20260104T160856 | Somewhat-Bullish | Relevance: 100%
- JPMorgan Chase (JPM.N) stock closed 1.0% higher at $325.48 on the first trading day of 2026, ahead of its Q4 and full-year earnings report on January 13. Investors will focus on net interest income, trading and investment banking activity, and management's 2026 expense commentary, especially given a projected $105 billion in expenses. The Institute for Supply Management's manufacturing report and upcoming Federal Reserve meeting on Jan 27-28 are also key macro catalysts.

**4. The Truth About JPMorgan Chase & Co: Why Everyone Is Betting On This Banking Beast**
- Source: AD HOC NEWS | 20260104T160856 | Bullish | Relevance: 100%
- JPMorgan Chase & Co (JPM) is gaining significant attention from both Wall Street and social media, positioning it as a popular choice for investors. The article explores whether JPM stock is a worthwhile investment, highlighting its stability, dividend payouts, and technological advancements. It compares JPM to competitors like Bank of America and concludes it's a solid long-term addition for diversified portfolios.

**5. Permanent Capital Management LP Invests $1.17 Million in JPMorgan Chase & Co. $JPM**
- Source: MarketBeat | 20260104T101320 | Somewhat-Bullish | Relevance: 100%
- Permanent Capital Management LP initiated a new position in JPMorgan Chase & Co. during the third quarter, acquiring 3,710 shares valued at approximately $1.17 million. Wall Street sentiment is mixed but generally supportive, with a consensus "Hold" rating and a target price of $329.19, following strong Q3 earnings where JPMorgan beat estimates with an EPS of $5.07 and revenue of $47.12 billion. The company also declared a quarterly dividend of $1.50, equating to a 1.8% annual yield.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Barclays | $391 | $342 | +14% |
| 2025-12-18 | Truist Securiti | $330 | $319 | +3% |
| 2025-12-17 | Keefe, Bruyette | $363 | $354 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Barclays | main | Overweight |
| 2025-12-18 | Truist Securiti | main | Hold |
| 2025-12-17 | Keefe, Bruyette | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.18M) |
| Sells | 5 ($0.45M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-2.2%)
- Blackrock Inc.: 7.7% (+1.6%)
- State Street Corpora: 4.6% (-0.1%)
- Morgan Stanley: 2.4% (-2.3%)
- Geode Capital Manage: 2.2% (+0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +7%) could attract flows.
- Momentum building: MRS_20 improving +2.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.78 signals overvaluation risk, limited margin of safety. Forward P/E 15.8x stretched relative to 5% growth. Quality metrics strong (margin 35%). Analyst sentiment positive (3 raises, avg +7%). Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $918.5B |
| Beta | 1.07 |
| 52W Range | $202.16 - $337.25 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.78 |
| Forward P/E | 15.8 |
| Current P/E | 16.6 |
| YoY Growth | 5.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.8% to 4.4% (+2.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 83rd percentile. MRS_5 at 2.4% confirms short-term momentum alignment. AM_20 at 4.5% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.79), confirming momentum. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.38% (CS: 84) | Strong |
| RSI_14 | 66.4 | Neutral |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.070x | Above |
| vs SMA200 | 1.166x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $334.10
- **Stop Loss:** $322.12 (3.6% risk)
- **Target:** $352.07 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 115
- **Position Value:** $38,421.50
- **Portfolio %:** 38.42%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-13 (Est: $4.92)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.87 | $5.07 | +4.0% |
| 2025Q2 | $4.47 | $4.96 | +10.9% |
| 2025Q1 | $4.64 | $5.07 | +9.2% |
| 2024Q4 | $4.04 | $4.81 | +19.2% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*